{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:28:30Z","timestamp":1784744910519,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ctrv.2024.102849","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:51:01Z","timestamp":1729788661000},"page":"102849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["False Positive Rate from Prospective Studies of PET-CT in Cutaneous Malignant Melanoma: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"131","author":[{"given":"B.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Church-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Hardwicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ctrv.2024.102849_b0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pop.2015.07.006","article-title":"Skin Cancer","volume":"42","author":"Linares","year":"2015","journal-title":"Prim Care"},{"key":"10.1016\/j.ctrv.2024.102849_b0010","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"33","key":"10.1016\/j.ctrv.2024.102849_b0015","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1200\/JCO.2012.47.3728","article-title":"Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry","volume":"31","author":"Geller","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102849_b0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1751-1097.2007.00226.x","article-title":"The protective role of melanin against UV damage in human skin","volume":"84","author":"Brenner","year":"2008","journal-title":"Photochem Photobiol"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102849_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5826\/dpc.0702a01","article-title":"Epidemiological trends in skin cancer","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol Pract Concept"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102849_b0030","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031","volume":"136","author":"Whiteman","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ctrv.2024.102849_b0035","unstructured":"UK CR. Melanoma Skin Cancer Mortality Statistics 2020 [Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/melanoma-skin-cancer\/mortality#heading-Zero."},{"issue":"12","key":"10.1016\/j.ctrv.2024.102849_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126395","article-title":"Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances","volume":"22","author":"Strashilov","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctrv.2024.102849_b0045","doi-asserted-by":"crossref","unstructured":"Keung EZ, Gershenwald JE. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther. 2018;18(8):775-84.","DOI":"10.1080\/14737140.2018.1489246"},{"key":"10.1016\/j.ctrv.2024.102849_b0050","article-title":"Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma","volume":"7(7):CD012806","author":"Dinnes","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102849_b0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.coms.2021.11.004","article-title":"Imaging and Laboratory Workup for Melanoma","volume":"34","author":"Kaleem","year":"2022","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102849_b0060","first-page":"207","article-title":"Melanoma Radiological Surveillance: A Review of Current Evidence and Clinical Challenges","volume":"93","author":"Howard","year":"2020","journal-title":"Yale J Biol Med"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102849_b0065","first-page":"168","article-title":"Evaluation of PET\/CT in patients with stage III malignant cutaneous melanoma","volume":"9","author":"Groen","year":"2019","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102849_b0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.17159\/2078-5151\/2019\/v57n3a2832","article-title":"The utility of PET-CT in the staging and management of advanced and recurrent malignant melanoma","volume":"57","author":"Twycross","year":"2019","journal-title":"S Afr J Surg"},{"issue":"7","key":"10.1016\/j.ctrv.2024.102849_b0075","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/annonc\/mdy124","article-title":"Surveillance imaging with FDG-PET\/CT in the post-operative follow-up of stage 3 melanoma","volume":"29","author":"Lewin","year":"2018","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ctrv.2024.102849_b0080","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/bjc.2017.254","article-title":"Tumour mutation status and sites of metastasis in patients with cutaneous melanoma","volume":"117","author":"Adler","year":"2017","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102849_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4329\/wjr.v5.i2.25","article-title":"Melanoma metastases in the abdomen and pelvis: Frequency and patterns of spread","volume":"5","author":"Trout","year":"2013","journal-title":"World J Radiol"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102849_b0090","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.rcl.2021.05.007","article-title":"Precision Nuclear Medicine: The Evolving Role of PET in Melanoma","volume":"59","author":"Wright","year":"2021","journal-title":"Radiol Clin North Am"},{"issue":"12","key":"10.1016\/j.ctrv.2024.102849_b0095","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1016\/j.ejso.2021.06.011","article-title":"Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients","volume":"47","author":"Helvind","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102849_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpet.2014.07.006","article-title":"The Basic Principles of FDG-PET\/CT Imaging","volume":"9","author":"Basu","year":"2014","journal-title":"PET Clin"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102849_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0256-4947.75771","article-title":"18F-FDG PET\/CT imaging in oncology","volume":"31","author":"Almuhaideb","year":"2011","journal-title":"Ann Saudi Med"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102849_b0110","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","article-title":"Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy","volume":"31","author":"Kinahan","year":"2010","journal-title":"Semin Ultrasound CT MR"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102849_b0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.suronc.2014.01.002","article-title":"Value of positron emission tomography scan in stage III cutaneous melanoma: a systematic review and meta-analysis","volume":"23","author":"Rodriguez Rivera","year":"2014","journal-title":"Surg Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102849_b0120","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1148\/radiol.2493080240","article-title":"Role of PET in the initial staging of cutaneous malignant melanoma: systematic review","volume":"249","author":"Krug","year":"2008","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102849_b0125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00259-009-1224-8","article-title":"Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma","volume":"37","author":"Jimenez-Requena","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ctrv.2024.102849_b0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/2046-4053-1-62","article-title":"F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET\/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review","volume":"1","author":"Schroer-Gunther","year":"2012","journal-title":"Syst Rev"},{"key":"10.1016\/j.ctrv.2024.102849_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110107","article-title":"Prognostic value of 2-[(18)F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy","volume":"146","author":"Schweighofer-Zwink","year":"2022","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102849_b0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40644-020-00322-1","article-title":"Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing (18)F-FDG-PET\/CT: a comparison with serologic markers of tumor burden and inflammation","volume":"20","author":"Reinert","year":"2020","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ctrv.2024.102849_b0145","unstructured":"Excellence NIfHaC. Melanoma: Assesment and Management NG14 2022 [Available from: .www.nice.org.uk\/guidance\/ng14."},{"key":"10.1016\/j.ctrv.2024.102849_b0150","unstructured":"Network NCC. NCCN Guidelines for Patients: Melanoma 2023 [Available from: https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/melanoma-patient.pdf."},{"key":"10.1016\/j.ctrv.2024.102849_b0155","doi-asserted-by":"crossref","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer. 2022;170:236-55.","DOI":"10.1016\/j.ejca.2022.03.008"},{"issue":"12","key":"10.1016\/j.ctrv.2024.102849_b0160","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/annonc\/mdz411","article-title":"clinicalguidelines@esmo.org EGCEa. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger","volume":"30","author":"Michielin","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2024.102849_b0165","unstructured":"Australia CC. Clinical Practice Guidelines for the diagnosis and management of melanoma 2020 [Available from: https:\/\/www.cancer.org.au\/clinical-guidelines\/skin-cancer\/melanoma."},{"issue":"6","key":"10.1016\/j.ctrv.2024.102849_b0170","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1245\/s10434-019-07311-0","article-title":"False-Positive Results and Incidental Findings with Annual CT or PET\/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma","volume":"26","author":"Nijhuis","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102849_b0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3348\/kjr.2006.7.1.57","article-title":"False positive and false negative FDG-PET scans in various thoracic diseases","volume":"7","author":"Chang","year":"2006","journal-title":"Korean J Radiol"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102849_b0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1370\/afm.1466","article-title":"Long-term psychosocial consequences of false-positive screening mammography","volume":"11","author":"Brodersen","year":"2013","journal-title":"Ann Fam Med"},{"issue":"42","key":"10.1016\/j.ctrv.2024.102849_b0185","doi-asserted-by":"crossref","first-page":"e7415","DOI":"10.1097\/MD.0000000000007415","article-title":"Retrospective analysis for the false positive diagnosis of PET-CT scan in lung cancer patients","volume":"96","author":"Feng","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.ctrv.2024.102849_b0190","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1158\/1055-9965.2126.13.12","article-title":"The economic impact of false-positive cancer screens","volume":"13","author":"Lafata","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ctrv.2024.102849_b0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.critrevonc.2019.05.010","article-title":"Proportion of false-positive follow-up FDG-PET scans in lymphoma: Systematic review and meta-analysis","volume":"141","author":"Adams","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"13","key":"10.1016\/j.ctrv.2024.102849_b0200","doi-asserted-by":"crossref","DOI":"10.3310\/hta17130","article-title":"Systematic review of the psychological consequences of false-positive screening mammograms","volume":"17","author":"Bond","year":"2013","journal-title":"Health Technol Assess"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102849_b0205","doi-asserted-by":"crossref","first-page":"e0281153","DOI":"10.1371\/journal.pone.0281153","article-title":"Estimating the lifetime risk of a false positive screening test result","volume":"18","author":"White","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102849_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16010215","article-title":"Diagnostic Performance of [(18)F]F-FDG Positron Emission Tomography (PET) in Non-Ophthalmic Malignant Melanoma: A Systematic Review and Meta-Analysis of More Than 10,000 Melanoma Patients","volume":"16","author":"Zamani-Siahkali","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctrv.2024.102849_b0215","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.ejrad.2016.08.011","article-title":"Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis","volume":"85","author":"Adams","year":"2016","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102849_b0220","first-page":"147","article-title":"PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings","volume":"59","author":"Garcia","year":"2017","journal-title":"Radiologia"},{"key":"10.1016\/j.ctrv.2024.102849_b0225","article-title":"Prevalence and outcomes of incidental imaging findings: umbrella review","volume":"361","author":"O'Sullivan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ctrv.2024.102849_b0230","first-page":"127","article-title":"Utility of Routine PET\/CT for Initial Staging of Patients with Sentinel Lymph Node Positive Melanoma","volume":"19","author":"Baker","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2024.102849_b0235","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1080\/0284186X.2016.1213879","article-title":"Whole body PET\/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma","volume":"55","author":"Koskivuo","year":"2016","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102849_b0240","first-page":"255","article-title":"The value of FDG PET\/CT for follow-up of patients with melanoma: a retrospective analysis","volume":"7","author":"Vensby","year":"2017","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.ctrv.2024.102849_b0245","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1245\/s10434-020-09270-3","article-title":"Performance of Long-Term CT and PET\/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma","volume":"28","author":"Turner","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102849_b0250","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1245\/s10434-010-1088-y","article-title":"Utility of preoperative 18F-FDG PET\/CT and brain MRI in melanoma patients with palpable lymph node metastases","volume":"17","author":"Aukema","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2024.102849_b0255","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/1471-2407-11-328","article-title":"Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma","volume":"11","author":"Peric","year":"2011","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102849_b0260","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejca.2006.11.014","article-title":"Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma","volume":"43","author":"Pfannenberg","year":"2007","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102849_b0265","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/CMR.0b013e32830b363b","article-title":"Preoperative 18F-FDG-PET\/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma","volume":"18","author":"Singh","year":"2008","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102849_b0270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13046-014-0096-3","article-title":"HF ultrasound vs PET-CT and telethermography in the diagnosis of In-transit metastases from melanoma: a prospective study and review of the literature","volume":"33","author":"Solivetti","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102849_b0275","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3413\/Nukmed-0584-13-05","article-title":"18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma","volume":"52","author":"Wieder","year":"2013","journal-title":"Nuklearmedizin"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102849_b0280","first-page":"15","article-title":"D'Incan M. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial","volume":"55","author":"Cachin","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102849_b0285","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/jdv.12078","article-title":"Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study","volume":"28","author":"Jouvet","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102849_b0290","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CMR.0b013e32815c10b0","article-title":"F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm","volume":"17","author":"Maubec","year":"2007","journal-title":"Melanoma Res"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102849_b0295","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.annder.2011.02.023","article-title":"Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography\/computed tomography (TEP\/CT) and CT","volume":"138","author":"Dellestable","year":"2011","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102849_b0300","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/radiol.2442061099","article-title":"High-risk melanoma: accuracy of FDG PET\/CT with added CT morphologic information for detection of metastases","volume":"244","author":"Strobel","year":"2007","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102849_b0305","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12149-021-01608-5","article-title":"Revisiting detection of in-transit metastases in melanoma patients using digital 18F-FDG PET\/CT with small-voxel reconstruction","volume":"35","author":"Zimmermann","year":"2021","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102849_b0310","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/CMR.0000000000000666","article-title":"Staging 18F-FDG PET\/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases","volume":"30","author":"Holtkamp","year":"2020","journal-title":"Melanoma Res"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102849_b0315","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jaad.2019.05.076","article-title":"Diagnostic accuracy of imaging studies for initial staging of T2b to T4b melanoma patients: A cross-sectional study","volume":"81","author":"Riquelme-McLoughlin","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102849_b0320","first-page":"17","article-title":"Positron emission tomography in the follow-up of cutaneous malignant melanoma patients: a systematic review","volume":"4","author":"Danielsen","year":"2013","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102849_b0325","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s13139-018-0537-6","article-title":"Recurrence of melanoma after initial treatment: diagnostic performance of FDG PET in posttreatment surveillance","volume":"52","author":"Lee","year":"2018","journal-title":"Nucl Med Mol Imag"},{"issue":"8","key":"10.1016\/j.ctrv.2024.102849_b0330","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s12094-019-02252-2","article-title":"Utility of PET\/CT in patients with stage I-III melanoma","volume":"22","author":"Aviles Izquierdo","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102849_b0335","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jso.26737","article-title":"18 F-FDG positron emission tomography-computed tomography has a low positive predictive value for detecting occult recurrence in asymptomatic patients with high-risk Stages IIB, IIC, and IIIA melanoma","volume":"125","author":"Jaeger","year":"2022","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2024.102849_b0340","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102849_b0345","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (MINORS): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102849_b0350","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/08445621221107108","article-title":"Sensitivity analysis: a method to promote certainty and transparency in nursing and health research","volume":"54","author":"Mowbray","year":"2022","journal-title":"Can J Nurs Res"},{"issue":"11","key":"10.1016\/j.ctrv.2024.102849_b0355","doi-asserted-by":"crossref","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737224001786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737224001786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T07:23:37Z","timestamp":1731655417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737224001786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":71,"alternative-id":["S0305737224001786"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2024.102849","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"False Positive Rate from Prospective Studies of PET-CT in Cutaneous Malignant Melanoma: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2024.102849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102849"}}